A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
Clinical trial NCT00381810 · TERMINATED
Trial details
- NCT number
- NCT00381810
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-22
- Primary completion
- 2008-07-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.